Zacks Research Issues Negative Outlook for CRL Earnings

Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) – Equities researchers at Zacks Research lowered their Q1 2025 earnings per share estimates for shares of Charles River Laboratories International in a research report issued on Thursday, April 10th. Zacks Research analyst R. Department now expects that the medical research company will post earnings per […]